Britain’s AstraZeneca said on Thursday that good data was coming in so far on its vaccine for Covid-19, already in large-scale human trials and widely seen as the front-runner in the race for a shot against the novel coronavirus.
Unlock the Full Story — Join Thousands of Informed Kenyans Today
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted